v3.25.4
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
Cash flows from operating activities:      
Net income $ 693 $ 526 $ 1,381
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 347 326 282
Share-based compensation expense 1,626 1,519 1,416
Amortization of deferred costs 292 251 213
Non-cash lease expense 116 103 96
Net (gains) losses on investments (87) 16 19
Accretion of discounts on marketable debt securities, net (61) (113) (149)
Deferred income taxes 218 33 (1,058)
Asset impairments 117 19 0
Other 7 (1) (17)
Changes in operating assets and liabilities, net of business combinations:      
Trade and other receivables, net (360) (313) (87)
Deferred costs (404) (337) (342)
Prepaid expenses and other assets (14) 50 69
Accounts payable 6 25 (72)
Accrued expenses and other liabilities (26) (41) (95)
Unearned revenue 469 398 493
Net cash provided by operating activities 2,939 2,461 2,149
Cash flows from investing activities:      
Purchases of marketable securities (2,721) (4,786) (6,150)
Maturities of marketable securities 2,339 3,846 4,519
Sales of marketable securities 2,937 273 144
Capital expenditures (162) (269) (232)
Business combinations, net of cash acquired (2,079) (825) (8)
Purchases of other intangible assets 0 (3) (10)
Purchases of non-marketable equity and other investments (21) (22) (16)
Sales of non-marketable equity and other investments 19 5 2
Other 21 0 0
Net cash provided by (used in) investing activities 333 (1,781) (1,751)
Cash flows from financing activities:      
Repurchases of common stock (2,895) (700) (423)
Proceeds from issuance of common stock from employee equity plans 192 186 177
Taxes paid related to net share settlement of equity awards (616) (636) (22)
Net cash used in financing activities (3,319) (1,150) (268)
Effect of exchange rate changes 2 0 (1)
Net increase (decrease) in cash, cash equivalents, and restricted cash (45) (470) 129
Cash, cash equivalents, and restricted cash at the beginning of period 1,554 2,024 1,895
Cash, cash equivalents, and restricted cash at the end of period 1,509 1,554 2,024
Supplemental cash flow data:      
Cash paid for interest 110 110 110
Non-cash investing and financing activities:      
Purchases of property and equipment, accrued but not paid 64 27 52
Taxes related to net share settlement of equity awards, accrued but not paid 11 13 0
Reconciliation of cash, cash equivalents, and restricted cash as shown in the Consolidated Statements of Cash Flows:      
Cash and cash equivalents 1,501 1,543 2,012
Restricted cash included in Prepaid expenses and other current assets 8 11 12
Total cash, cash equivalents, and restricted cash $ 1,509 $ 1,554 $ 2,024